PAUL C HO, MD
Osteopathic Medicine at Moanalua Rd, Honolulu, HI

License number
Hawaii MD-10961
Category
Osteopathic Medicine
Type
Cardiovascular Disease
License number
Hawaii MD-10961
Category
Osteopathic Medicine
Type
Interventional Cardiology
Address
Address
3288 Moanalua Rd, Honolulu, HI 96819
Phone
(808) 432-0000

Personal information

See more information about PAUL C HO at radaris.com
Name
Address
Phone
Paul Ho
88 Piikoi St APT 3903, Honolulu, HI 96814
(808) 591-2689
Paul Ho
1408 Liliha St, Honolulu, HI 96817
Paul Ho
94-101 Keahilele St, Mililani, HI 96789
(808) 623-9413

Organization information

See more information about PAUL C HO at bizstanding.com

Kaiser Permanente Medical - Paul C Ho MD

3288 Moanalua Rd, Honolulu, HI 96819

Categories:
Cardiology Physicians & Surgeons
Phone:
(808) 432-7870 (Phone)

Professional information

See more information about PAUL C HO at trustoria.com
Paul C Ho Photo 1
Dr. Paul C Ho, Honolulu HI - MD (Doctor of Medicine)

Dr. Paul C Ho, Honolulu HI - MD (Doctor of Medicine)

Specialties:
Cardiology, Interventional Cardiology
Address:
Kaiser Permanente Spclty Clin
3288 Moanalua Rd, Honolulu 96819
(808) 432-7870 (Phone)
Certifications:
Cardiovascular Disease, 1998, Internal Medicine, 1997, Interventional Cardiology, 2010
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Kaiser Permanente Spclty Clin
3288 Moanalua Rd, Honolulu 96819
Kaiser Foundation Hospital
3288 Moanalua Rd, Honolulu 96819
Education:
Medical School
Temple University
Graduated: 1992
Dartmouth Med Sch
Harvard U


Paul C Ho Photo 2
Paul C Ho, Honolulu HI

Paul C Ho, Honolulu HI

Specialties:
Cardiologist
Address:
3288 Moanalua Rd, Honolulu, HI 96819
Education:
Temple University, School of Medicine - Doctor of Medicine
Massachusetts General Hospital - Fellowship - Cardiology
Dartmouth-Hitchcock Medical Center - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Sub-certificate in Cardiovascular Disease (Internal Medicine), American Board of Internal Medicine Sub-certificate in Interventional Cardiology (Internal Medicine)


Paul Chungming Ho Photo 3
Paul Chungming Ho, Honolulu HI

Paul Chungming Ho, Honolulu HI

Specialties:
Allergy & Immunology, Internal Medicine, Cardiovascular Disease, Interventional Cardiology, Cardiology
Work:
Moanalua Medical Center
3288 Moanalua Rd, Honolulu, HI 96819
Education:
Temple University Physicians (1992)


Paul Ho Photo 4
Methods And Apparatus For Percutaneous Aortic Valve Replacement

Methods And Apparatus For Percutaneous Aortic Valve Replacement

US Patent:
2009003, Jan 29, 2009
Filed:
Jul 25, 2008
Appl. No.:
12/180223
Inventors:
Paul C. Ho - Honolulu HI, US
International Classification:
A61F 2/24, A61F 2/84
US Classification:
623 211, 623 21
Abstract:
A delivery system and method for percutaneous aortic valve (PAV) replacement and apparatus used therein. A temporary aortic valve comprised of a reversibly expandable occluding means, such as balloons, surrounds a central catheter mechanism. The temporary valve is positioned within the ascending aorta, just above and downstream from the coronary ostia. The occluding means is configured such that, when fully expanded against the aortic wall, gaps are left that promote continuous coronary perfusion during the cardiac cycle. The temporary valve with occluding means substitutes for the function of the native aortic valve during its replacement. The native aortic valve is next dilated, and then ablated through deployment of low profile, elongated, sequentially delivered stents. The ablation stent(s) displace the native valve tissues and remain within the aortic annulus to receive and provide a structure for retaining the PAV. The PAV is delivered, positioned and deployed within the ablation stent(s) at the aortic annulus with precision and relative ease. Ablation of the native aortic valve removes the structural obstacles to precise PAV placement. The temporary aortic valve mediates the hemodynamic forces upon the devices as encountered by the surgeon following native valve ablation. The temporary valve also promotes patient stability through continuous coronary perfusion and a moderated transvalvular pressure gradient and regurgitation. Sequential delivery of low profile PAV components minimize the risk of trauma and injury to vascular tissues. Mathematical considerations for determining the optimum cross-sectional area for the temporary valve blood perfusion gaps are also described.


Paul Ho Photo 5
Method And Apparatus For Percutaneous Aortic Valve Replacement

Method And Apparatus For Percutaneous Aortic Valve Replacement

US Patent:
2009003, Jan 29, 2009
Filed:
Jul 23, 2007
Appl. No.:
11/781924
Inventors:
Paul C. Ho - HONOLULU HI, US
International Classification:
A61F 2/06
US Classification:
623 124
Abstract:
A method for percutaneous aortic valve (PAV) replacement and a temporary aortic valve used to facilitate the same. The temporary valve is comprised of a reversibly expandable occluding means, such as balloons, surrounding a central catheter mechanism. The temporary valve is positioned within the ascending aorta, just above and downstream from the coronary ostia. The occluding means is configured such that, when fully expanded against the aortic wall, gaps are left that promote continuous coronary perfusion during the cardiac cycle. The native aortic valve is next dilated, and then ablated through deployment of an ablation stent. The ablation stent displaces the native valve tissues and remains within the aortic annulus to receive and retain the PAV. The PAV can then be positioned and deployed within the ablation stent with precision and ease. Ablation of the native aortic valve removes the structural obstacles to precise PAV placement. The temporary aortic valve mediates the hemodynamic forces encountered by the surgeon following native valve ablation. The temporary valve also promotes patient stability through continuous coronary perfusion and a moderated transvavlular pressure gradient. Mathematical considerations for determining the optimum cross-sectional area for the temporary valve blood perfusion gaps are also described.


Paul Ho Photo 6
Method And System For Balloon Counterpulsation During Aortic Valve Replacement

Method And System For Balloon Counterpulsation During Aortic Valve Replacement

US Patent:
2012011, May 10, 2012
Filed:
Sep 7, 2011
Appl. No.:
13/227276
Inventors:
Paul C. Ho - Honolulu HI, US
Assignee:
HOCOR Cardiovascular Technologies LLC - Honolulu HI
International Classification:
A61M 29/00
US Classification:
606194
Abstract:
Methods and systems for regulating aortic regurgitation during aortic valve replacement or repair procedures utilize a temporary aortic valve (TAV) catheter and a controller. The temporary aortic valve catheter has an expandable occlusion device which can partially occlude the aortic lumen during ventricular diastole with a lesser occlusion during ventricular systole. Exemplary balloon structures include multiple, independently inflatable balloons which are inflated in synchrony with the cardiac cycle by the controller. By controlling aortic regurgitation, the repair or replacement protocols can be conducted with less interference from blood flow.